ARCHIVES

Roferon A Application Marred By Mission Data, Protocol, Compliance

This article is from The Cancer Letter archive.

Vol. 25 No. 36 | September 24, 1999

Download PDF Visit The Full Archive

Related Articles

NY Attorney General Subpoenaes Amgen, J&J Over ESA Promotion.

May 25, 2007

Bunn Says ASCO Is “Strong, Diverse, Respected, Growing”

June 6, 2003

In Brief: Twenty Apply for ICC Director Job, DeVita Says 30 More Centers Needed; PAP Awards To Clark, Fox

March 18, 1983

Phase III Trial of Imbruvica Halted, Following Increases in Progression-Free Survival

January 31, 2014

Consortium Aims To Make Mice Whose Cancers Act Human.

January 7, 2000

Oral Sorafenib Trial Published in The Lancet; Tablets Extend PFS in Metastatic Disease

April 25, 2014